Synlett 2015; 26(06): 820-826
DOI: 10.1055/s-0034-1380119
letter
© Georg Thieme Verlag Stuttgart · New York

Water-Mediated Three-Component Wittig–SNAr Reactions

Zian Xu
Shanghai Key Laboratory of New Drug Design and School of Pharmacy, East China University of Science & Technology, 130 Mei-Long Road, Shanghai 200237, P. R. of China   Email: hwliu@ecust.edu.cn   Email: xhyu@ecust.edu.cn
,
Wanwan Zhai
Shanghai Key Laboratory of New Drug Design and School of Pharmacy, East China University of Science & Technology, 130 Mei-Long Road, Shanghai 200237, P. R. of China   Email: hwliu@ecust.edu.cn   Email: xhyu@ecust.edu.cn
,
Congpeng Feng
Shanghai Key Laboratory of New Drug Design and School of Pharmacy, East China University of Science & Technology, 130 Mei-Long Road, Shanghai 200237, P. R. of China   Email: hwliu@ecust.edu.cn   Email: xhyu@ecust.edu.cn
,
Hongwei Liu*
Shanghai Key Laboratory of New Drug Design and School of Pharmacy, East China University of Science & Technology, 130 Mei-Long Road, Shanghai 200237, P. R. of China   Email: hwliu@ecust.edu.cn   Email: xhyu@ecust.edu.cn
,
Jianhong Zhao*
Shanghai Key Laboratory of New Drug Design and School of Pharmacy, East China University of Science & Technology, 130 Mei-Long Road, Shanghai 200237, P. R. of China   Email: hwliu@ecust.edu.cn   Email: xhyu@ecust.edu.cn
,
Xinhong Yu*
Shanghai Key Laboratory of New Drug Design and School of Pharmacy, East China University of Science & Technology, 130 Mei-Long Road, Shanghai 200237, P. R. of China   Email: hwliu@ecust.edu.cn   Email: xhyu@ecust.edu.cn
› Author Affiliations
Further Information

Publication History

Received: 31 October 2014

Accepted after revision: 27 December 2014

Publication Date:
10 February 2015 (online)


Preview

Abstract

A novel one-pot, three-component Wittig–SNAr approach to ethyl (E)-3-[4-(morpholino-1-yl)-3-nitrophenyl]acrylate, ethyl (E)-3-[3-cyano-4-(morpholino-1-yl)phenyl]acrylates, ethyl (E)-3-[2-(morpholino-1-yl)-5-nitrophenyl]acrylate, ethyl (E)-3-[5-(morpholino-1-yl)-4-nirtofuryl-2-yl]acrylates, and their analogues, which would be used as intermediates of aurora 2 kinase inhibitors ,etc. has been developed starting from readily available nitro- or cyano-group-activated haloaromatic aldehydes, secondary amines, quaternary phosphonium salts, and sodium hydroxide, using water as a solvent, with high stereoselectivity and in moderate to high yield. The noteworthy features of this one-pot, three-component process is highlighted by its rapid and highly efficient formation of a new C(sp2)–N bond and a new C(sp2)–C(sp2) double bond using water as a simple nontoxic convenient and environmentally benign solvent under metal-free mild reaction conditions.

Supporting Information